Incyte Corporation (INCY)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | GARDNER, DAVID H | EVP, Chief Strategy Officer | Common Stock | Disposal | 920 | 126.93 |
| Sep 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Disposal | 9,233 | 120.5 |
| Sep 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Acquisition | 9,233 | 71.93 |
| Sep 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Acquisition | 6,477 | 64.25 |
| Sep 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Disposal | 13,985 | 120.49 |
| Sep 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Employee Stock Option (right to buy) | Disposal | 9,233 | 0 |
| Sep 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Employee Stock Option (right to buy) | Disposal | 6,477 | 0 |
| Sep 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Acquisition | 2,957 | 61.76 |
| Sep 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Employee Stock Option (right to buy) | Disposal | 4,551 | 0 |
| Sep 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Employee Stock Option (right to buy) | Disposal | 2,957 | 0 |
| Sep 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Acquisition | 4,551 | 61.18 |
| Aug 25, 2026 | BASI, RAMITPAL K | EVP, Human Resources | Common Stock | Disposal | 504 | 129.72 |
| Aug 19, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Disposal | 10,801 | 125.56 |
| Aug 12, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Disposal | 10,803 | 120.04 |
| Aug 5, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 2,207 | 0 |
| Aug 5, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Disposal | 10,640 | 122.69 |
| Aug 5, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 2,207 | 123.99 |
| Aug 5, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 2,207 | 106.47 |
| Aug 3, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 6,055 | 120.43 |
| Aug 3, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 6,055 | 105.43 |
| Aug 3, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 6,055 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 5,332 | 119.42 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 2,187 | 119.47 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 2,623 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 3,023 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 2,284 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 2,072 | 71.93 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 3,148 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 9,459 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 6,171 | 119.43 |
| Jul 31, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Disposal | 15,888 | 119.7 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 3,023 | 83.2 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 2,623 | 74.78 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 2,072 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 3,148 | 68.62 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 2,284 | 64.25 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 4,695 | 119.39 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 9,459 | 72.27 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 2,918 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 1,643 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 14,661 | 119.46 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 326 | 121.69 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 2,864 | 119.4 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 85 | 106.47 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 1,642 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 2,864 | 77.67 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 326 | 105.43 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 85 | 122.19 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 2,709 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 2,293 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 1,643 | 119.51 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 1,643 | 80.5 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 2,918 | 61.18 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 1,642 | 119.38 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 85 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 326 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Disposal | 2,864 | 0 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 1,642 | 85.01 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 2,293 | 119.41 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 2,293 | 90.56 |
| Jul 31, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 2,709 | 61.76 |
| Jul 23, 2026 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Performance Shares | Acquisition | 8,999 | 0 |
| Jul 23, 2026 | HEESON, LEE | EVP, Head of Incyte Intl | Employee Stock Option (right to buy) | Acquisition | 15,423 | 0 |
| Jul 23, 2026 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Employee Stock Option (right to buy) | Acquisition | 6,426 | 0 |
| Jul 23, 2026 | HEESON, LEE | EVP, Head of Incyte Intl | Performance Shares | Acquisition | 13,498 | 0 |
| Jul 16, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Acquisition | 13,403 | 0 |
| Jul 16, 2026 | ISSA, MOHAMED KHAIRIE | EVP, Head of U.S. Commercial | Performance Shares | Acquisition | 19,643 | 0 |
| Jul 16, 2026 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Performance Shares | Acquisition | 24,496 | 0 |
| Jul 16, 2026 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Common Stock | Acquisition | 9,798 | 0 |
| Jul 16, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Acquisition | 5,916 | 0 |
| Jul 16, 2026 | MEURY, WILLIAM | Director, Chief Executive Officer | Common Stock | Acquisition | 26,807 | 0 |
| Jul 16, 2026 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Employee Stock Option (right to buy) | Acquisition | 42,298 | 0 |
| Jul 16, 2026 | GARDNER, DAVID H | EVP, Chief Strategy Officer | Employee Stock Option (right to buy) | Acquisition | 31,923 | 0 |
| Jul 16, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Employee Stock Option (right to buy) | Acquisition | 57,861 | 0 |
| Jul 16, 2026 | BASI, RAMITPAL K | EVP, Human Resources | Performance Shares | Acquisition | 12,479 | 0 |
| Jul 16, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Acquisition | 25,538 | 0 |
| Jul 16, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Performance Shares | Acquisition | 14,790 | 0 |
| Jul 16, 2026 | BASI, RAMITPAL K | EVP, Human Resources | Employee Stock Option (right to buy) | Acquisition | 21,548 | 0 |
| Jul 16, 2026 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Acquisition | 2,834 | 0 |
| Jul 16, 2026 | TRAY, THOMAS | Principal Accounting Officer | Employee Stock Option (right to buy) | Acquisition | 4,079 | 0 |
| Jul 16, 2026 | MEURY, WILLIAM | Director, Chief Executive Officer | Performance Shares | Acquisition | 80,421 | 0 |
| Jul 16, 2026 | ISSA, MOHAMED KHAIRIE | EVP, Head of U.S. Commercial | Common Stock | Acquisition | 7,857 | 0 |
| Jul 16, 2026 | HOFFMAN, RICHARD A. | EVP & General Counsel | Performance Shares | Acquisition | 18,487 | 0 |
| Jul 16, 2026 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Common Stock | Disposal | 1,877 | 114.73 |
| Jul 16, 2026 | HOFFMAN, RICHARD A. | EVP & General Counsel | Common Stock | Acquisition | 7,395 | 0 |
| Jul 16, 2026 | HOFFMAN, RICHARD A. | EVP & General Counsel | Employee Stock Option (right to buy) | Acquisition | 31,923 | 0 |
| Jul 16, 2026 | GARDNER, DAVID H | EVP, Chief Strategy Officer | Performance Shares | Acquisition | 18,487 | 0 |
| Jul 16, 2026 | GARDNER, DAVID H | EVP, Chief Strategy Officer | Common Stock | Acquisition | 7,395 | 0 |
| Jul 16, 2026 | BASI, RAMITPAL K | EVP, Human Resources | Common Stock | Acquisition | 4,991 | 0 |
| Jul 16, 2026 | MEURY, WILLIAM | Director, Chief Executive Officer | Employee Stock Option (right to buy) | Acquisition | 77,148 | 0 |
| Jul 16, 2026 | ISSA, MOHAMED KHAIRIE | EVP, Head of U.S. Commercial | Employee Stock Option (right to buy) | Acquisition | 33,918 | 0 |
| Jul 16, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Performance Shares | Acquisition | 33,508 | 0 |
| Jul 16, 2026 | ISSA, MOHAMED KHAIRIE | EVP, Head of U.S. Commercial | Common Stock | Disposal | 1,093 | 115.01 |
| Jul 15, 2026 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Common Stock | Disposal | 3,088 | 115.09 |
| Jul 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Disposal | 4,950 | 115.09 |
| Jul 15, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 1,512 | 115.09 |
| Jul 15, 2026 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Common Stock | Disposal | 28,237 | 113.05 |
| Jul 15, 2026 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Disposal | 1,098 | 115.09 |
| Jul 15, 2026 | ISSA, MOHAMED KHAIRIE | EVP, Head of U.S. Commercial | Common Stock | Disposal | 1,099 | 115.09 |
| Jul 14, 2026 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Common Stock | Disposal | 21,830 | 114.88 |
| Jul 14, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Disposal | 17,969 | 114.88 |
| Jul 14, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 437 | 114.88 |
| Jul 14, 2026 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Disposal | 692 | 114.88 |
| Jul 2, 2026 | MEURY, WILLIAM | Director, Chief Executive Officer, President | Common Stock | Disposal | 4,779 | 116.86 |
| Jul 2, 2026 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Common Stock | Disposal | 2,177 | 116.86 |
| Jul 2, 2026 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Disposal | 477 | 116.86 |
| Jul 2, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 350 | 116.86 |
| Jun 30, 2026 | HARRIGAN, EDMUND | Director | Common Stock | Acquisition | 255 | 113.36 |
| Jun 30, 2026 | CLANCY, PAUL J | Director | Common Stock | Acquisition | 252 | 113.36 |
| Jun 30, 2026 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Common Stock | Acquisition | 400 | 0 |
| Jun 8, 2026 | HARRIGAN, EDMUND | Director | Common Stock | Acquisition | 1,642 | 0 |
| Jun 8, 2026 | BRAWLEY, OTIS W | Director | Non Qualfied Stock Option (right to buy) | Acquisition | 6,111 | 0 |
| Jun 8, 2026 | FOUSE, JACQUALYN A | Director | Common Stock | Acquisition | 1,642 | 0 |
| Jun 8, 2026 | BRAWLEY, OTIS W | Director | Common Stock | Acquisition | 1,642 | 0 |
| Jun 8, 2026 | HARRIGAN, EDMUND | Director | Non Qualfied Stock Option (right to buy) | Acquisition | 6,111 | 0 |
| Jun 8, 2026 | BIENAIME, JEAN JACQUES | Director | Non Qualfied Stock Option (right to buy) | Acquisition | 6,111 | 0 |
| Jun 8, 2026 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Non-Qualified Stock Options (right to buy) | Acquisition | 6,111 | 0 |
| Jun 8, 2026 | HIGH, KATHERINE A | Director | Common Stock | Acquisition | 1,642 | 0 |
| Jun 8, 2026 | CLANCY, PAUL J | Director | Common Stock | Acquisition | 1,642 | 0 |
| Jun 8, 2026 | CLANCY, PAUL J | Director | Non Qualfied Stock Option (right to buy) | Acquisition | 6,111 | 0 |
| Jun 8, 2026 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Common Stock | Acquisition | 1,642 | 0 |
| Jun 8, 2026 | HIGH, KATHERINE A | Director | Non Qualfied Stock Option (right to buy) | Acquisition | 6,111 | 0 |
| Jun 8, 2026 | BIENAIME, JEAN JACQUES | Director | Common Stock | Acquisition | 1,642 | 0 |
| Jun 8, 2026 | FOUSE, JACQUALYN A | Director | Non Qualfied Stock Option (right to buy) | Acquisition | 6,111 | 0 |
| Jun 4, 2026 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Acquisition | 2,639 | 83.83 |
| Jun 4, 2026 | TRAY, THOMAS | Principal Accounting Officer | Non-Qualified Stock Option (right to buy) | Disposal | 2,639 | 0 |
| Jun 4, 2026 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Disposal | 2,639 | 100 |
| Jun 1, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Disposal | 25,469 | 95.59 |
| May 26, 2026 | BIENAIME, JEAN JACQUES | Director | Common Stock | Acquisition | 15,000 | 84.53 |
| May 26, 2026 | BIENAIME, JEAN JACQUES | Director | Non-Qualified Stock Option (right to buy) | Disposal | 15,000 | 0 |
| May 26, 2026 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Disposal | 2,051 | 97.35 |
| May 26, 2026 | BIENAIME, JEAN JACQUES | Director | Common Stock | Disposal | 13,059 | 97.1 |
| May 19, 2026 | CLANCY, PAUL J | Director | Non-Qualified Stock Option (right to buy) | Disposal | 15,000 | 0 |
| May 19, 2026 | CLANCY, PAUL J | Director | Non-Qualified Stock Option (right to buy) | Disposal | 15,000 | 0 |
| May 19, 2026 | CLANCY, PAUL J | Director | Common Stock | Acquisition | 15,000 | 84.53 |
| May 19, 2026 | CLANCY, PAUL J | Director | Common Stock | Acquisition | 15,000 | 84.53 |
| May 19, 2026 | CLANCY, PAUL J | Director | Common Stock | Disposal | 15,000 | 94.93 |
| May 19, 2026 | CLANCY, PAUL J | Director | Common Stock | Disposal | 15,000 | 94.93 |
| May 8, 2026 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Non-Qualified Stock Options | Disposal | 15,000 | 0 |
| May 8, 2026 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Common Stock | Acquisition | 15,000 | 84.53 |
| May 6, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Acquisition | 31,517 | 0 |
| May 6, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Acquisition | 31,517 | 0 |
| May 6, 2026 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Common Stock | Acquisition | 44,124 | 0 |
| May 6, 2026 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Common Stock | Acquisition | 44,124 | 0 |
| May 4, 2026 | UPADHYAY, SUKETU | EVP & Chief Financial Officer | Employee Stock Option (right to buy) | Acquisition | 38,429 | 0 |
| May 4, 2026 | UPADHYAY, SUKETU | EVP & Chief Financial Officer | Common Stock | Acquisition | 26,343 | 0 |
| May 4, 2026 | UPADHYAY, SUKETU | EVP & Chief Financial Officer | Performance Shares | Acquisition | 13,171 | 0 |
| Apr 17, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Employee Stock Option (right to buy) | Disposal | 12,590 | 0 |
| Apr 17, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Employee Stock Option (right to buy) | Disposal | 6,077 | 0 |
| Apr 17, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Acquisition | 12,590 | 71.93 |
| Apr 17, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Acquisition | 6,077 | 64.25 |
| Apr 17, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Disposal | 18,667 | 96.5 |
| Apr 15, 2026 | STEIN, STEVEN H | CMO & Head of Late-Stage Dev. | Common Stock | Acquisition | 39,049 | 0 |
| Apr 15, 2026 | CAGNONI, PABLO J | President, Global Head of R&D | Common Stock | Acquisition | 27,892 | 0 |
| Apr 15, 2026 | MEURY, WILLIAM | Director, Chief Executive Officer, President | Common Stock | Acquisition | 125,000 | 0 |
| Mar 31, 2026 | CLANCY, PAUL J | Director | Common Stock | Acquisition | 265 | 94.12 |
| Mar 31, 2026 | HARRIGAN, EDMUND | Director | Common Stock | Acquisition | 269 | 94.12 |
| Mar 31, 2026 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Common Stock | Acquisition | 421 | 0 |
| Mar 25, 2026 | TROTTA, MATTEO | EVP, GM, Dermatology US | Common Stock | Disposal | 537 | 92.23 |
| Mar 17, 2026 | CAGNONI, PABLO J | President, R&D | Common Stock | Acquisition | 7,166 | 61.18 |
| Mar 17, 2026 | CAGNONI, PABLO J | President, R&D | Common Stock | Disposal | 18,667 | 94.24 |
| Mar 17, 2026 | CAGNONI, PABLO J | President, R&D | Common Stock | Acquisition | 11,501 | 64.25 |
| Mar 17, 2026 | CAGNONI, PABLO J | President, R&D | Employee Stock Option (right to buy) | Disposal | 11,501 | 0 |
| Mar 17, 2026 | CAGNONI, PABLO J | President, R&D | Employee Stock Option (right to buy) | Disposal | 7,166 | 0 |
| Feb 19, 2026 | CAGNONI, PABLO J | President, R&D | Common Stock | Acquisition | 5,575 | 61.18 |
| Feb 19, 2026 | CAGNONI, PABLO J | President, R&D | Common Stock | Acquisition | 13,093 | 61.76 |
| Feb 19, 2026 | CAGNONI, PABLO J | President, R&D | Employee Stock Option (right to buy) | Disposal | 5,575 | 0 |
| Feb 19, 2026 | CAGNONI, PABLO J | President, R&D | Employee Stock Option (right to buy) | Disposal | 13,093 | 0 |
| Feb 19, 2026 | CAGNONI, PABLO J | President, R&D | Common Stock | Disposal | 18,668 | 100.91 |
| Feb 2, 2026 | HEESON, LEE | EVP, Head of Incyte Intl | Common Stock | Disposal | 111 | 102.67 |
| Feb 2, 2026 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Common Stock | Disposal | 185 | 102.67 |
| Jan 20, 2026 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Common Stock | Disposal | 429 | 102.62 |
| Jan 16, 2026 | CAGNONI, PABLO J | President, R&D | Employee Stock Option (right to buy) | Acquisition | 28,475 | 0 |
| Jan 16, 2026 | ISSA, MOHAMED KHAIRIE | EVP, Head of US Oncology | Employee Stock Option (right to buy) | Acquisition | 14,237 | 0 |
| Jan 16, 2026 | HEESON, LEE | EVP, Head of Incyte Intl | Common Stock | Acquisition | 8,911 | 0 |
| Jan 16, 2026 | TROTTA, MATTEO | EVP, GM, Dermatology US | Employee Stock Option (right to buy) | Acquisition | 8,542 | 0 |
| Jan 16, 2026 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Employee Stock Option (right to buy) | Acquisition | 4,218 | 0 |
| Jan 16, 2026 | TRAY, THOMAS | Principal Accounting Officer | Employee Stock Option (right to buy) | Acquisition | 2,425 | 0 |
| Jan 16, 2026 | STEIN, STEVEN H | EVP & Chief Medical Officer | Employee Stock Option (right to buy) | Acquisition | 19,932 | 0 |
| Jan 16, 2026 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Common Stock | Acquisition | 7,426 | 0 |
| Jan 7, 2026 | ISSA, MOHAMED KHAIRIE | EVP, Head of US Oncology | Common Stock | Disposal | 10,856 | 109.07 |
| Jan 6, 2026 | ISSA, MOHAMED KHAIRIE | EVP, Head of US Oncology | Common Stock | Disposal | 8,264 | 106.66 |
| Jan 5, 2026 | STEIN, STEVEN H | EVP & Chief Medical Officer | Common Stock | Disposal | 15,634 | 101.7 |
| Dec 31, 2025 | HARRIGAN, EDMUND | Director | Common Stock | Acquisition | 245 | 98.77 |
| Dec 31, 2025 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Common Stock | Acquisition | 328 | 0 |
| Dec 31, 2025 | CLANCY, PAUL J | Director | Common Stock | Acquisition | 241 | 98.77 |
| Dec 31, 2025 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Common Stock | Disposal | 254 | 98.77 |
| Dec 31, 2025 | STEIN, STEVEN H | EVP & Chief Medical Officer | Common Stock | Disposal | 13,292 | 98.77 |
| Dec 19, 2025 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Acquisition | 1,044 | 95.76 |
| Dec 19, 2025 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Disposal | 2,774 | 100 |
| Dec 19, 2025 | TRAY, THOMAS | Principal Accounting Officer | Non-Qualified Stock Option (right to buy) | Disposal | 1,730 | 0 |
| Dec 19, 2025 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Acquisition | 1,730 | 95.76 |
| Dec 19, 2025 | TRAY, THOMAS | Principal Accounting Officer | Incentive Stock Option (right to buy) | Disposal | 1,044 | 0 |
| Dec 18, 2025 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Disposal | 600 | 98.25 |
| Dec 17, 2025 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Common Stock | Disposal | 4,323 | 97.26 |
| Dec 16, 2025 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Common Stock | Disposal | 53,175 | 97.29 |
| Dec 16, 2025 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Common Stock | Disposal | 833 | 97.42 |
| Dec 11, 2025 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 255 | 94.94 |
| Dec 10, 2025 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 5,553 | 95.58 |
| Dec 8, 2025 | HOPPENOT, HERVE | Director | Common Stock | Disposal | 2,843 | 96.7 |
| Dec 2, 2025 | STEIN, STEVEN H | EVP & Chief Medical Officer | Common Stock | Disposal | 20,105 | 102.51 |
| Dec 1, 2025 | STEIN, STEVEN H | EVP & Chief Medical Officer | Common Stock | Disposal | 2,559 | 102.96 |
| Dec 1, 2025 | HOFFMAN, RICHARD A. | EVP & General Counsel | Employee Stock Option (right to buy) | Acquisition | 43,301 | 0 |
| Dec 1, 2025 | MORRISSEY, MICHAEL JAMES | EVP, Head of Tech. Operations | Common Stock | Disposal | 326 | 102.04 |
| Dec 1, 2025 | HOFFMAN, RICHARD A. | EVP & General Counsel | Performance Shares | Acquisition | 23,665 | 0 |
| Dec 1, 2025 | STEIN, STEVEN H | EVP & Chief Medical Officer | Common Stock | Disposal | 17,093 | 102.04 |
| Dec 1, 2025 | HOFFMAN, RICHARD A. | EVP & General Counsel | Common Stock | Acquisition | 9,466 | 0 |
| Nov 24, 2025 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Disposal | 600 | 103 |
| Nov 21, 2025 | TRAY, THOMAS | Principal Accounting Officer | Common Stock | Disposal | 169 | 102 |
| Nov 17, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Common Stock | Acquisition | 278 | 64.25 |
| Nov 17, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Common Stock | Disposal | 278 | 104.36 |
| Nov 17, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Employee Stock Option (right to buy) | Disposal | 278 | 0 |
| Nov 10, 2025 | HOPPENOT, HERVE | Director | Common Stock | Disposal | 187,500 | 105.46 |
| Nov 5, 2025 | STEIN, STEVEN H | EVP & Chief Medical Officer | Non-Qualified Stock Option (right to buy) | Disposal | 2,995 | 0 |
| Nov 5, 2025 | STEIN, STEVEN H | EVP & Chief Medical Officer | Incentive Stock Option (right to buy) | Disposal | 1,044 | 0 |
| Nov 5, 2025 | STEIN, STEVEN H | EVP & Chief Medical Officer | Common Stock | Acquisition | 1,194 | 83.83 |
| Nov 5, 2025 | STEIN, STEVEN H | EVP & Chief Medical Officer | Non-Qualified Stock Option (right to buy) | Disposal | 1,194 | 0 |
| Nov 5, 2025 | STEIN, STEVEN H | EVP & Chief Medical Officer | Common Stock | Disposal | 5,233 | 102.2 |
| Nov 5, 2025 | STEIN, STEVEN H | EVP & Chief Medical Officer | Common Stock | Acquisition | 1,044 | 95.76 |
| Nov 5, 2025 | STEIN, STEVEN H | EVP & Chief Medical Officer | Common Stock | Acquisition | 2,995 | 95.76 |
| Nov 4, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Employee Stock Option (right to buy) | Disposal | 598 | 0 |
| Nov 4, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Common Stock | Acquisition | 598 | 58.06 |
| Nov 4, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Common Stock | Disposal | 598 | 101.36 |
| Nov 3, 2025 | HEESON, LEE | EVP, Head of Incyte Intl | Common Stock | Disposal | 3,074 | 94.02 |
| Oct 15, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Common Stock | Acquisition | 277 | 64.25 |
| Oct 15, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Common Stock | Disposal | 277 | 85.13 |
| Oct 15, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Employee Stock Option (right to buy) | Disposal | 277 | 0 |
| Oct 3, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Common Stock | Disposal | 3,501 | 85.54 |
| Oct 2, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Employee Stock Option (right to buy) | Disposal | 599 | 0 |
| Oct 2, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Common Stock | Acquisition | 599 | 58.06 |
| Oct 2, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Common Stock | Disposal | 599 | 87.65 |
| Oct 2, 2025 | DENTON, SHEILA A. | EVP & General Counsel | Common Stock | Disposal | 3,130 | 86.28 |
| Oct 1, 2025 | HEESON, LEE | EVP, Head of Incyte Intl | Common Stock | Disposal | 463 | 86.7 |
| Oct 1, 2025 | MAYES, PATRICK A | EVP & Chief Scientific Officer | Common Stock | Disposal | 1,569 | 86.7 |
| Sep 30, 2025 | HARRIGAN, EDMUND | Director | Common Stock | Acquisition | 289 | 84.81 |
| Sep 30, 2025 | BAKER, BROS. ADVISORS LP | Director, 10% Owner | Common Stock | Acquisition | 388 | 0 |
| Sep 30, 2025 | CLANCY, PAUL J | Director | Common Stock | Acquisition | 285 | 84.81 |